About Marie Guillou

This author has not yet filled in any details.
So far Marie Guillou has created 386 blog entries.

AOU di Modena – Italy

2024-12-13T14:21:17+01:00

AOU di Modena - Modena (IT) Reference centre Contact information Azienda Ospedaliero-Universitaria di Modena Via del Pozzo, 71, 41125 Modena MO, Italiy [...]

AOU di Modena – Italy2024-12-13T14:21:17+01:00

S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)

2024-09-20T14:56:46+02:00

S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)

S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)2024-09-20T14:56:46+02:00

CMTC-OVM – Mosaic

2023-07-10T11:37:50+02:00

Cutaneous Mosaic Disorders : Naevi & Naevoid skin disorders – Complex vascular malformations and cutaneous and subcutaneous vascular tumors CMTC-OVM CMTC-OVM provides a [...]

CMTC-OVM – Mosaic2023-07-10T11:37:50+02:00

A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement

2024-09-20T15:06:55+02:00

A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement

A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement2024-09-20T15:06:55+02:00

Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia

2024-09-20T15:03:00+02:00

Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia

Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia2024-09-20T15:03:00+02:00